Table 2 PPI information associated with the 24 nephrology trials selected
From: Patient and Public Involvement (PPI) in outcome selection in breast cancer and nephrology trials
Trial IDs | Trial registration number | PPI information in study publication | PPI information in the study protocol | PPI information in supplementary files |
|---|---|---|---|---|
Trial 1 | No | No | No | |
Trial 2 | No | No | No | |
Trial 3 | No | No | No | |
Trial 4 | No | No | No | |
Trial 5 | No | No | No | |
Trial 6 | No | No | No | |
Trial 7 | No | No | No | |
Trial 8 | No | No | No | |
Trial 9 | No | No | No | |
Trial 10 | No | No | No | |
Trial 11 | No | No | No | |
Trial 12 | No | No | No | |
Trial 13 | No | No | No | |
Trial 14 | No | No | No | |
Trial 15 | No | No | No | |
Trial 16 | No | No | No | |
Trial 17 | No | No | No | |
Trial 18 | No | No | No | |
Trial 19 | No | No | No | |
Trial 20 | No (steering committee members do not appear to be patients or patient representatives) | No | No | |
Trial 21 | No | No | No | |
Trial 22 | No | No | No | |
Trial 23 | Yes (interviews with some patients to test enrolment efficiency but patients were not involved in outcome selection)a | No. “In generating the protocol, we did not specifically ask for patient input, since an existing drug (sodium polystyrene sulfonate) is ingested by patients on a similar schedule and for the same reasons. That drug is not very effective and has known side effects. Our goal was to make the drug much more effective and with fewer side effects. I felt that all of my patients taking the older drug would agree with this goal and the protocol”. | No | |
Trial 24 | No | No | No |